Assessment of therapeutic response in brain tuberculomas using serial dynamic contrast-enhanced MRI

被引:16
|
作者
Haris, M. [1 ]
Gupta, R. K. [1 ]
Husain, M. [5 ]
Srivastava, C. [5 ]
Singh, A. [7 ]
Rathore, R. K. Singh [7 ]
Saksena, S.
Behari, S. [2 ]
Husain, N. [6 ]
Pandey, C. Mohan [3 ]
Prasad, K. Nath [4 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Radiol, MR Sect, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurosurg, Lucknow 226014, Uttar Pradesh, India
[3] Sanjay Gandhi Postgrad Inst Med Sci, Dept Biostat, Lucknow 226014, Uttar Pradesh, India
[4] Sanjay Gandhi Postgrad Inst Med Sci, Dept Microbiol, Lucknow 226014, Uttar Pradesh, India
[5] King Georges Med Univ, Dept Neurol, Lucknow, Uttar Pradesh, India
[6] King Georges Med Univ, Dept Pathol, Lucknow, Uttar Pradesh, India
[7] Indian Inst Technol, Dept Math & Stat, Kanpur 208016, Uttar Pradesh, India
关键词
D O I
10.1016/j.crad.2007.11.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To assess the most useful dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) index in the evaluation of the therapeutic response in brain tuberculoma (BT) patients. SUBJECTS AND METHODS: Twenty-three patients with 25 BT lesions were serially evaluated using DCE MRI. All lesions were classified into two groups: group I (n = 15) included patients who showed clinical, as well as imaging, improvement; and group II (n = 10) included patients with either clinical or radiological deterioration. The group I and group II lesions were examined for up to 12 months at 4 monthly intervals. However, the lesions in five patients of group II were excised following clinical deterioration after 4 months of therapy. The perfusion indices, i.e., relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF), permeability (k(trans)), and leakage (V-e), were quantified at each time point. The cellular, necrotic, and total volumes of lesion, together with the oedema volume, were also calculated. RESULTS: All patients in group I and three in group II showed a significant decrease in all perfusion indices, together with the oedema volume, after 1 year. In these three patients in group II, increase in rCBV was associated with increased cellular volume fraction whereas the k(trans), v(e), and oedema volume decreased significantly after 4 months. In five patients in group II who underwent excision of the lesion after 4 months of therapy due to clinical deterioration, the decrease in rCBV was associated with significant increase in k(trans) and oedema volume without any significant change in lesion volume. The rCBV correlated significantly with the cellular volume, whereas ktrans showed a significant correlation with the v, and oedema volume at each time point. CONCLUSION: In BT, changes in ktrans and oedema volume are associated with a therapeutic response at 4 months, even when there is a paradoxical increase in the lesion volume. (C) 2007 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:562 / 574
页数:13
相关论文
共 50 条
  • [1] Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI
    Wang, Chunhao
    Subashi, Ergys
    Yin, Fang-Fang
    Chang, Zheng
    MEDICAL PHYSICS, 2016, 43 (03) : 1335 - 1347
  • [2] Assessment of ameloblastomas using MRI and dynamic contrast-enhanced MRI
    Asaumi, J
    Hisatomi, M
    Yanagi, Y
    Matsuzaki, H
    Choi, YS
    Kawai, N
    Konouchi, H
    Kishi, K
    EUROPEAN JOURNAL OF RADIOLOGY, 2005, 56 (01) : 25 - 30
  • [3] Evaluation of Transcytolemmal Water Exchange Analysis For Therapeutic Response Assessment Using Dynamic Contrast-Enhanced MRI
    Wang, C.
    Subashi, E.
    Liang, X.
    Yin, F.
    Chang, Z.
    MEDICAL PHYSICS, 2016, 43 (06) : 3443 - 3443
  • [4] Evaluation of Dynamic Fractal Signature Dissimilarity as a Novel Biomarker in Therapeutic Response Assessment Using Dynamic Contrast-Enhanced MRI
    Wang, C.
    Subashi, E.
    Yin, F.
    Chang, Z.
    MEDICAL PHYSICS, 2015, 42 (06) : 3733 - 3733
  • [5] Therapeutic response assessment of RFA for HCC:Contrast-enhanced US,CT and MRI
    Yasunori Minami
    Naoshi Nishida
    Masatoshi Kudo
    World Journal of Gastroenterology, 2014, (15) : 4160 - 4166
  • [6] Therapeutic response assessment of RFA for HCC: Contrast-enhanced US, CT and MRI
    Minami, Yasunori
    Nishida, Naoshi
    Kudo, Masatoshi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (15) : 4160 - 4166
  • [7] Rectal cancer: Assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI
    Oberholzer, Katja
    Menig, Matthias
    Pohlmann, Andreas
    Junginger, Theodor
    Heintz, Achim
    Kreft, Andreas
    Hansen, Torsten
    Schneider, Astrid
    Lollert, Andre
    Schmidberger, Heinz
    Christoph, Dueber
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2013, 38 (01) : 119 - 126
  • [8] Dynamic Contrast-Enhanced MRI for Assessing Therapeutic Response of Choroidal Neovascularization in a Rat Model
    Kim, Jae-Hun
    Im, Geun Ho
    Yoon, Jaemoon
    Yang, Jehoon
    Chung, Julius Juhyun
    Cha, Ji Hoon
    Kim, Sun I.
    Ham, Don-il
    Lee, Jung Hee
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (12) : 7693 - 7700
  • [9] Multiparametric Characterization of Response to Anti-angiogenic Therapy Using USPIO Contrast-Enhanced MRI in Combination with Dynamic Contrast-Enhanced MRI
    Kim, Jana
    Kim, Eugene
    Euceda, Leslie R.
    Meyer, Dan E.
    Langseth, Karina
    Bathen, Tone F.
    Moestue, Siver A.
    Huuse, Else Marie
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 47 (06) : 1589 - 1600
  • [10] Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI
    Jung, Brian C.
    Arevalo-Perez, Julio
    Lyo, John K.
    Holodny, Andrei I.
    Karimi, Sasan
    Young, Robert J.
    Peck, Kyung K.
    JOURNAL OF NEUROIMAGING, 2016, 26 (02) : 240 - 246